These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15674366)

  • 21. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML).
    Carnicer MJ; Lasa A; Buschbeck M; Serrano E; Carricondo M; Brunet S; Aventin A; Sierra J; Di Croce L; Nomdedeu JF
    Ann Hematol; 2008 Oct; 87(10):819-27. PubMed ID: 18587575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation.
    Nanri T; Uike N; Kawakita T; Iwanaga E; Mitsuya H; Asou N
    Genes Chromosomes Cancer; 2010 Mar; 49(3):237-41. PubMed ID: 19953636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
    Pabst T; Mueller BU
    Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
    Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
    Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
    Dufour A; Schneider F; Hoster E; Benthaus T; Ksienzyk B; Schneider S; Kakadia PM; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Subklewe M; Hiddemann W; Bohlander SK; Spiekermann K;
    Ann Hematol; 2012 Jul; 91(7):1051-63. PubMed ID: 22362118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
    Fröhling S; Schlenk RF; Krauter J; Thiede C; Ehninger G; Haase D; Harder L; Kreitmeier S; Scholl C; Caligiuri MA; Bloomfield CD; Döhner H; Döhner K
    Genes Chromosomes Cancer; 2005 Apr; 42(4):427-32. PubMed ID: 15645492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CEBPalpha mutations in childhood acute myeloid leukemia.
    Liang DC; Shih LY; Huang CF; Hung IJ; Yang CP; Liu HC; Jaing TH; Wang LY; Chang WH
    Leukemia; 2005 Mar; 19(3):410-4. PubMed ID: 15618961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
    Schuster MB; Porse BT
    Biofactors; 2009; 35(3):227-31. PubMed ID: 19322763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.
    Lin TC; Hou HA; Chou WC; Ou DL; Yu SL; Tien HF; Lin LI
    Leukemia; 2011 Jan; 25(1):32-40. PubMed ID: 20927134
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Mannelli F; Ponziani V; Bencini S; Bonetti MI; Benelli M; Cutini I; Gianfaldoni G; Scappini B; Pancani F; Piccini M; Rondelli T; Caporale R; Gelli AM; Peruzzi B; Chiarini M; Borlenghi E; Spinelli O; Giupponi D; Zanghì P; Bassan R; Rambaldi A; Rossi G; Bosi A
    Haematologica; 2017 Mar; 102(3):529-540. PubMed ID: 28250006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the bZip region of the CEBPA gene: A novel prognostic factor in patients with acute myeloid leukemia.
    Rivera JC; Nuñez D; Millar E; Ramirez K; Chandía M; Aguayo C
    Int J Lab Hematol; 2023 Dec; 45(6):833-838. PubMed ID: 37621152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C/EBPα dysregulation in AML and ALL.
    Paz-Priel I; Friedman A
    Crit Rev Oncog; 2011; 16(1-2):93-102. PubMed ID: 22150310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
    Fuchs O; Provaznikova D; Kocova M; Kostecka A; Cvekova P; Neuwirtova R; Kobylka P; Cermak J; Brezinova J; Schwarz J; Markova J; Salaj P; Klamova H; Maaloufova J; Lemez P; Novakova L; Benesova K
    Blood Cells Mol Dis; 2008; 40(3):401-5. PubMed ID: 18182175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family.
    Wafa A; Ali B; Moassass F; Kheder M; Aljapawe A; Al-Halabi B; Mrasek K; Liehr T; Al-Achkar W
    Mol Genet Genomic Med; 2022 Feb; 10(2):e1854. PubMed ID: 35032366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype.
    Kim S; Kim DH; Jang JH; Jung CW; Jang MA; Ki CS; Kim JW; Kim SH; Kim HJ
    Ann Lab Med; 2012 Mar; 32(2):153-7. PubMed ID: 22389883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
    Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia].
    Zhao JM; Wang HW; Xu ZF; Zhu L; Bai B; Ge XY
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):299-302. PubMed ID: 15949295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia.
    Juhl-Christensen C; Bomberg M; Melsvik D; Hokland P; Nyvold CG
    Eur J Haematol; 2008 Oct; 81(4):273-80. PubMed ID: 18616509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.